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The extracellular matrix (ECM) physically supports cells and influences stem cell
behaviour, modulating kinase‐mediated signalling cascades. Cell‐derived ECMs
have emerged in bone regeneration as they reproduce physiological tissue‐
architecture and ameliorate mesenchymal stromal cell (MSC) properties. Titanium
scaffolds show good mechanical properties, facilitate cell adhesion, and have been
routinely used for bone tissue engineering (BTE). We analyzed the kinomic
signature of human MSCs in adhesion to an osteopromotive osteoblast‐derived
ECM, and compared it to MSCs on titanium. PamChip kinase‐array analysis
revealed 63 phosphorylated peptides on ECM and 59 on titanium, with MSCs on
ECM exhibiting significantly higher kinase activity than on titanium. MSCs on the
two substrates showed overlapping kinome profiles, with activation of similar
signalling pathways (FAK, ERK, and PI3K signalling). Inhibition of PI3K signalling in
cells significantly reduced adhesion to ECM and increased the number of
nonadherent cells on both substrates. In summary, this study comprehensively
characterized the kinase activity in MSCs on cell‐derived ECM and titanium,
highlighting the role of PI3K signalling in kinomic changes regulating osteoblast
viability and adhesion. Kinome profile analysis represents a powerful tool to select
pathways to better understand cell behaviour. Osteoblast‐derived ECM could be
further investigated as titanium scaffold‐coating to improve BTE.
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1 | INTRODUCTION
The extracellular matrix (ECM) is an essential structural component
present in every tissue, which physically supports cells, but also
actively modulates their behaviour, by regulating the availability of
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bioactive molecules and by transducing mechanical signalling (Discher,
Mooney, & Zandstra, 2009; Guilak et al., 2009; Hynes, 2009; Reilly &
Engler, 2010). Bone matrix is composed of collagen and noncollagen-
ous proteins to maintain bone flexibility, whereas its stiffness is
achieved by hydroxyapatite crystals, which makes bone a peculiar type
of connective tissue (Alford & Hankenson, 2006; Gentili & Cancedda,
2009). Because of its composition, bone ECM is essential for the
structure and the strength of the bone and it also actively participates
in bone formation and bone metabolism, by regulating mineralization
and modulating growth factor availability (Alford & Hankenson, 2006;
Bonewald & Dallas, 1994). The physical cues of bone ECM proteins are
mechanosensed by bone cells via integrin‐mediated signalling, which
converts the biomechanical properties of the ECM, eventually acting
on cell adhesion, proliferation and differentiation (Grzesik & Robey,
1994; Hidalgo‐Bastida & Cartmell, 2010; Marie, Haÿ, & Saidak, 2014).
The molecular details of the signalling pathways that mediate the relay
of information from integrin engagement to altered cellular physiology
remain, however, largely obscure.
In recent years, the interest in bone ECM for regenerative
purposes has grown rapidly. Bone tissue engineering (BTE) applica-
tions have been proposed as bone graft substitutes in large bone
defects when bone healing capacity is lost. BTE involves the
combination of scaffolds (osteoconduction), osteogenic factors
(osteoinduction), and autologous mesenchymal stromal cells (MSCs;
osteogenesis) to mimic the native bone ECM structure and stimulate
the osteogenic differentiation of local progenitors, driving new bone
formation (Gemini‐Piperni, Takamori et al., 2014; Meijer, de Bruijn,
Koole, & van Blitterswijk, 2007). Scaffolds serve as a structural
template for osteogenesis, being biocompatible and osteoconductive
(Bose, Roy, & Bandyopadhyay, 2012). Among the several scaffolds
that can be used for BTE, titanium shows good mechanical properties
and it can be tailored in porosity to suit cell adhesion. Although not
bioresorbable, titanium scaffolds are already clinically used for
orthopaedic and dental implants and in load‐bearing areas for their
good mechanical properties (Holland & Mikos, 2006). As scaffolds do
not reproduce the native structure of bone ECM, decellularized
ECMs represent an alternative cell‐instructive microenvironment to
guide endogenous repair (Badylak, Freytes, & Gilbert, 2009; Benders
et al., 2013). In this context, cell‐secreted ECMs have also been
proposed, as they are readily available and can be customized for the
use as scaffold‐coating (Decaris, Binder, Soicher, Bhat, & Leach, 2012;
Fitzpatrick & McDevitt, 2015; Hoshiba, Lu, Kawazoe, & Chen, 2010).
We and others demonstrated that osteoblast‐derived ECM stimu-
lates MSC osteogenesis and promotes bone formation ( Baroncelli M.,
just accepted; Datta, Holtorf, Sikavitsas, Jansen, & Mikos, 2005;
Mauney, Kaplan, & Volloch, 2004). Moreover, cell‐secreted ECMs
have already been used to coat and modify titanium surfaces,
showing that ECM influences gene expression and enhances
osteogenic differentiation of MSCs (Datta, et al., 2005; Q. P. Pham,
et al., 2008; M. T. Pham, Reuther, & Maitz, 2003). In this context, the
aim of this study was to compare the naturally secreted devitalized
ECM to titanium and investigate how they differentially regulate cell
adhesion.
Kinase activity lies at the core of cell signal transduction, as
activation of specific kinases mediates the induction of signalling
cascades resulting into cellular processes such as cell metabolism,
differentiation, and cytoskeletal rearrangements during cell adhesion
(Peppelenbosch, Frijns, & Fuhler, 2016; Robertson, et al., 2015;
Zaidel‐Bar & Geiger, 2010; Zambuzzi, Coelho, Alves, & Granjeiro,
2011). Integrin‐mediated activation of kinase signalling cascades
such as FAK and Src family kinase converts mechanical forces into
biochemical signals and results in the efficient adhesion of the cell to
the surface. At the same time, deregulation of kinase‐mediated
signalling pathways leads to pathological states, emphasizing that
studying kinase activity is crucial to understand biological functions.
The aim of our study was to assess specific kinomic changes
upon MSC adhesion to cell‐derived ECM and titanium surfaces, by
using tyrosine‐kinase PamChip® array which to the best of our
knowledge has not been used before to investigate cell adhesion of
human MSCs.
2 | MATERIALS AND METHODS
2.1 | Cell culture and ECM preparations
Human bone marrow‐derived MSCs were used to prepare the
osteopromotive devitalized ECM as previously described (Baroncelli
et al., 2017). Briefly, MSCs (5,128 viable cells/cm2; PT‐2501; Lonza,
Walkersville, MD) from a single donor at passage seven were
cultured in growth medium for 2 days (α‐Mem phenol‐red free
[Gibco, Paisley, UK], 10% foetal bovine serum), and osteogenically
differentiated for 11 days (culture medium supplemented with
100 nM of dexamethasone and 10mM of β glycerophosphate
[Sigma‐Aldrich, St. Louis, MO] to induce the deposition of the ECM.
MSCs were devitalized by freeze–thaw cycles, DNAse treatment
(10 U/ml; Sigma‐Aldrich), extensive washings with phosphate buffer
saline (PBS; Gibco), and sterile air drying. Devitalized ECMs were
stored at −20°C until further use.
2.2 | Tyrosine‐kinase activity profiling using
PamChip peptide microarray
To check the effect of the devitalized ECM and titanium on MSC
behaviour, MSCs (28,300 viable cells/cm2) were cultured on these
surfaces in growth medium. After 4 hr, cells were scraped in M‐PER
mammalian protein extraction buffer (ThermoFisher Scientific, Rock-
ford, IL) containing halt phosphatase and protease inhibitors
(ThermoFisher Scientific), allowed to lyse at 4°C for 10min and
lysates were cleared by centrifugation at 14,000g for 10min.
Supernatants were stored at −80°C until use. Cell lysates (5 μg
protein for all samples) were loaded on a PamChip tyrosine‐kinase
microarray (PamGene International BV, ’s‐Hertogenbosch, The
Netherlands). PamChip® is a high‐throughput and cost‐effective
peptide array that allows the study of kinome profile changes
without a priori assumptions (Peppelenbosch, 2012). In the PamChip
platform, cell lysates are continuously pumped past 144 consensus
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peptide‐sequences spotted on a three‐dimensional porous micro-
array, and the phosphorylation of their specific target substrates by
kinases present in the whole cell lysate is fluorescently detected,
describing the entire tyrosine‐kinase activity profile within a single
experiment (Diks et al., 2004; Lemeer et al., 2007; Sikkema et al.,
2009). Phosphorylation of the 144 kinase substrates on the array
was detected by using FITC‐labelled secondary antibody. After array
washing, images were taken every 5min to create real‐time kinetics
data. Signal intensities of the three technical replicates for each
substrate were quantified using Bionavigator software (version
6.1.42.1; PamGene International BV). A complete list of phosphopep-
tides on PamChip is depicted in Supporting Information Table 1. The
internal positive control peptide ART_003_EAI(pY)AAPFAKKKXC
was not considered for further analysis. Kinase reactions start at
t = 640 s. Subsequently, kinase reactions for different peptides show
markedly different kinetics. Most peptides act according to classical
biochemical theory, with the derivative of the initial reaction speed
approximating maximal velocity (Vmax) for phosphorylation of this
peptides. For data analysis of these peptides Vmax was established by
calculating the tangent of apparent peptide phosphorylation between
640 and 1,040 s and were classified as early Vmax peptides
(Supporting Information Figure 1a). Phosphorylation of other
peptides showed considerable lag time, followed by a quick rise in
speed of phosphorylation and subsequent decay according to
conventional biochemical theory, yielding sigmoid curves of substrate
phosphorylation when plotted against the time domain. For peptides
which upon visual inspection displayed such a Maxwell–Boltzmann‐
like activation kinetics, Vmax was calculated by determining the
tangent of substrate phosphorylation between 1,040 and 1,440 s and
were classified as mid Vmax (Supporting Information Figure 1b).
Finally, a group of peptides displayed very slow initial activation
followed by a rapid increase in reaction velocity toward the end of
the experiment. These peptides were identified by inspection of the
visual aspect of the curve and classified as late Vmax, whereas Vmax
was calculated by using the tangent of apparent substrate phosphor-
ylation between 1,440 and 1,840 s (Supporting Information
Figure 1c). A detailed flowchart of kinome profile analysis is
presented in Supporting Information Figure 1d. Vmax values below
zero were artificially set to zero. Only Vmax values with average
above zero were considered for further analysis. Markov state
analysis was performed to determine “on” and “off” calls of peptide
phosphorylation on ECM and titanium (Alves et al., 2015). In detail,
for each substrate the 143 peptides were ranked for Vmax intensity,
and a linear trend line was set for the lowest 60 peptides considered
as background. Peptides whose average phosphorylation minus 1.95
times the standard deviation being higher than the background signal
were considered as Markov‐positive “on” calls and further analyzed
(Supporting Information Figure 2a,b).
2.3 | Kinome array analysis
Protein and gene annotations of the kinase substrates on PamChip
were searched through Uniprot Knowledgebase (www.uniprot.org).
Markov‐positive peptides were analyzed through Qiagen’s Ingenu-
ity® Pathway Analysis (IPA®; Qiagen Redwood City; www.qiagen.
com/ingenuity) against human genome provided by Ingenuity Knowl-
edge Base as background. Gene IDs of the parent proteins of
Markov‐positive peptides on ECM and titanium were used in IPA. As
the peptide ART_004_EAIYAAPFAKKKXC is phosphorylated by
ABL1 kinase if artificial (Kua et al., 2012) as in our case, ABL1 was
also included in the IPA analysis. Consensus phosphopeptides
representing different phosphorylation sites of the same protein
were considered together. The Canonical Pathway analysis tool was
used for IPA analysis. Intracellular signalling pathways not restricted
to a specific cellular type were selected and used to generate the
heat map using R, together with the relative Gene IDs of the
phosphorylated kinase substrates.
Because specific kinases activate signalling cascades, the kinase
substrates that were phosphorylated in cells on ECM and on titanium
were further fitted into signalling pathways and cell‐related functions
as previously described (Sikkema et al., 2009) to confirm IPA analysis.
2.4 | Immunoblot analysis
Some of the activated kinases revealed by PamChip array were
validated by western blot analysis as described (with modifications;
Fuhler et al., 2009; Queiroz et al., 2012). Briefly, cell lysates (40 µg)
were prepared as for kinome profile analysis, mixed with 2× Laemmli
buffer, separated by sodium dodecyl sulfate‐polyacrylamide gel
electrophoresis, transferred onto nitrocellulose membrane (Immobi-
lon FL membrane; Merck KGaA, Darmstadt, Germany) and non-
specifically blocked with Odyssey buffer (LI‐COR Biosciences,
Lincoln, NE). Membranes were incubated overnight with primary
antibodies against pFAK (Y925; rabbit polyclonal; Signalway Anti-
body, College Park, MD), pERK, pPKB, pEGFR, and pSMAD1/5/8
(Cell Signaling Technology, Beverly, MA) and β‐actin loading control
(mouse monoclonal; Clone sc‐47778; Santa Cruz Biotechnology,
Dallas, TX). All antibodies were used 1:1,000. Membranes were
probed with secondary antibody conjugated with goat‐anti‐mouse‐
Alexa Fluor 680 and goat‐anti‐rabbit IRDye 800CW at 1:5,000 (LI‐
COR Biosciences). Odyssey infra‐red imaging (LI‐COR Biosciences)
was used to detect proteins. Quantification was performed using
Odyssey 3.0 software.
2.5 | Cell viability analysis
To assess the effect of PI3K signalling inhibition on cell viability, PI3K
signalling was inhibited by Wortmannin or LY294002 (Okada,
Sakuma, Fukui, Hazeki, & Ui, 1994). MSCs were cultured on ECM
for 4 hr in growth culture medium in the presence of 10 μM of
Wortmannin (in dimethyl sulfoxide [DMSO]; Sigma), 10 μM of
LY294002 (in DMSO; Cayman Chemical, Ann Arbor, MI) or vehicle
control. After 4 hr, MSCs were gently rinsed with PBS and both
floating and adherent cells were collected in Laemmli buffer.
To confirm that Wortmannin and LY294002 effectively inhibited
PI3K signalling, cell lysates treated with and without PI3K inhibitors
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were probed for the presence of pPKB and pERK (p42/44) by
immunoblot analysis.
To investigate if the PI3K inhibitors affected cell viability, the
presence of poly‐ADP‐ribose polymerase (PARP) and caspase 3 and
its relative cleaved forms were detected by western blot analysis
(antibodies from Cell Signaling Technology; Somasundaram
et al., 2013).
2.6 | Cell adhesion analysis
To check the effect of PI3K signalling inhibition on cell adhesion,
MSCs were cultured in osteogenic conditions on cell‐derived
ECM, in the presence of increasing concentrations of Wortmannin
and LY294002 (0.1, 1, and 10 μM in DMSO for both). MSCs in
adhesion to titanium with and without the highest concentration
of Wortmannin and LY294002 (10 μM in DMSO) were used for
the same purpose. MSCs with vehicle were considered as control
(1/200 vol/vol). After 4 hr, both floating cells and cells adhering to
the substrates were collected and the fraction of adhering cells
was quantified by Flow Cytometry (Accuri C6 Flow Cytometer;
BD Biosciences, San Jose, CA), using counting beads (Liquid
Counting Beads, BD Biosciences).
2.7 | Statistical analysis
Area under curve (AUC) of the kinetic reaction was calculated for
each Markov‐positive peptide, and nonparametric Wilcoxon
matched‐pairs signed rank test used to calculate significance.
Functional attachment data were representative of three
independent experiments, with one or two technical replicates per
each experiment, and all values were displayed as average ± standard
deviation of biological replicates otherwise indicated elsewhere.
One‐way analysis of variance, followed by Bonferroni post hoc test
was used to calculate significance, unless otherwise indicated.
3 | RESULTS
3.1 | PamChip array showed similar
tyrosine‐kinase activity profiles of MSCs on ECM
and on titanium
To investigate how surfaces influence cell behaviour, we cultured
MSCs for 4 hr on either an osteopromotive osteoblast‐derived ECM
or on titanium and analyzed the kinome profiles by a high‐throughput
tyrosine‐kinase PamChip microarray system. Maximal velocity (Vmax)
as the slope of phosphorylation kinetics was used as measure of
peptide phosphorylation and depending on the kinetic behaviour
observed, peptides were categorized as either early Vmax, mid Vmax,
or late Vmax (see Supporting Information Figure 1a–c for examples).
Following Markov state analysis, lysates obtained from MSCs
cultured on ECM yielded significant phosphorylation of 43 early
Vmax peptides, 16 mid Vmax peptides, and 4 late Vmax peptides
(Figure 1a, Supporting Information Figure 2a). Thus, a total of 63 “on
calls” were detected over time on ECM and considered for further
analysis (Figure 1a; complete list in Table 1).
On titanium, 37 peptides were phosphorylated with maximum
reaction speed early in the analysis, with an additional 10 at mid stage
and 12 at later stages (Supporting Information Figure 2b), yielding a total
of 59 Markov‐positive peptides phosphorylated on titanium over time
(Figure 1b; complete list in Table 1). Scatter plots show the correlation of
peptides at early, mid, and late stage in MSCs on ECM and on titanium
are shown in Supporting Information Figure 2c,d. On both surfaces, the
correlation is stronger between mid and late peptides.
Figure 1c shows the number of phosphorylated peptides on ECM
and on titanium. Despite a similar number of peptides being
phosphorylated on the two substrates, cultures on ECM induced a
significantly higher overall phosphorylation compared to titanium
(AUC of 34.1 ± 7.6 vs. 27.6 ± 6.5, P < 0.0001, data not shown). Several
of the peptides that were significantly phosphorylated early in MSCs
cultured on ECM, only achieved significant phosphorylation at later
time points when cells were cultured on titanium, suggesting lower
levels of active kinase present in these latter lysates. Comparing the
kinase activity profiles, most of the phosphorylated peptides (55)
were shared between the two substrates, highlighting a substantial
overlap between the kinome profiles of MSCs in ECM and titanium,
whereas eight kinase substrates were exclusively phosphorylated on
the cell‐derived ECM and four on titanium (Figure 1c).
F IGURE 1 Kinome profiling of MSCs cultured on cell‐derived
ECM and on titanium. (a) A total of 63 peptides on PamChip were
phosphorylated by kinases in MSCs on ECM over time: 43 as early
peptides, 16 as mid peptides, and 4 as late peptides. Only
Markov‐positive peptides are considered. (b) A total of 59 peptides
were phosphorylated on titanium over time: 37 peptides were
detected since early stages, 10 were phosphorylated at mid stages,
and 12 at late stages. Only Markov‐positive peptides are considered.
(c) Venn diagram showing the number of peptides phosphorylated on
both ECM and titanium (55), uniquely phosphorylated on ECM (8),
and uniquely phosphorylated on titanium (4). Unique peptides are
indicated in the tables. ECM: extracellular matrix;
MSC: mesenchymal stromal cell
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3.2 | PamChip array revealed activation of
PI3K/AKT signalling pathway
We analyzed the identified activated kinase‐mediated signalling
cascades by IPA, to unravel meaningful signalling changes upon cell
adhesion. The 63 kinase substrates phosphorylated on ECM and the
59 on titanium were involved in many signalling pathways (complete
list in Supporting Information Table 2 for ECM and Supporting
Information Table 3 for titanium). We further focused on intracellular
signallings, not specific for a selected cell type, resulting in a total of
30 parent gene IDs of the Markov‐positive peptides on ECM and on
titanium, involved in 35 selected intracellular signalling pathways, as
shown in the heat map in Figure 2. For ECM, the most induced
kinases (11) were involved in phosphatase and tensin homologue
(PTEN) signalling (p = 5.01 × 10−15), but also Tec kinase signalling
(p = 3.16 × 10−13). Signalling cascades activated upon integrin activa-
tion such as FAK, PAK, Paxillin, and ILK signalling pathways were also
activated (p = 3.98 × 10−14, 2.51 × 10−12, 3.09 × 10−10, 2.39 × 10−8,
respectively). Of the activated kinases, 10 are identified in IPA as
regulating ERK/MAPK signalling, and seven modulate PI3K/AKT
signalling (p = 5.01 × 10−11 and 2.08 × 10−8, respectively). Moreover,
Mitogen‐activated protein kinase 1 (MAPK1; peptide
MK01_180_192), phosphorylated only on ECM, was involved in most
of the signalling pathways, together with phosphatidylinositol 3‐
kinase regulatory subunit α (PI3KR1; peptide P85A_600_612) and
fibroblast growth factor receptor 3 (FGFR3; peptide
FGFR3_753_765). These last kinase substrates were phosphorylated
also on titanium, together with tyrosine‐protein phosphatase non-
receptor type 11 (PTPN11; peptide PTN11_539_551), which was
uniquely phosphorylated in MSCs on titanium and involved in most of
the activated signalling pathways (Figure 2). Most of the kinases
activated on titanium were involved in nuclear factor κ‐light‐chain‐
enhancer of activated B cells (NF‐κB) signalling (p = 2.51 × 10−13), Tec
kinase signalling (p = 5.01 × 10−12), and PTEN signalling
(p = 6.30 × 10−12). PAK, FAK, Paxillin, and ILK signalling pathways
were activated on titanium as on the ECM (p = 7.94 × 10−11,
6.30 × 10−11, 2.29 × 10−17, and 5.75 × 10−6, respectively), as well as
ERK/MAPK (p = 3.46 × 10−7) and PI3K/AKT (p = 1.91 × 10−4), con-
firming the overlap between these substrates.
IPA analysis revealed that the activated kinases were involved in
multiple signalling cascades. In addition, we used the results of the
peptide array to fit each kinase that phosphorylates a selected
peptide into one specific signalling pathway, as previously done
(Sikkema et al., 2009), in a more biased approach but more
osteoblast‐oriented (complete list in Supporting Information Table
4). This approach confirmed the IPA analysis, as of the 63 kinase
substrates phosphorylated on ECM, four induced the activation of
FAK signalling and a total of 11 phosphopeptides were involved in
cytoskeletal functions (Supporting Information Figure 3a,b; Support-
ing Information Table 5). Three peptides were clustered in MAPK
signalling and three in PI3K signalling, illustrating that different
approaches in kinase clustering lead to similar conclusions. Similar
findings were found by clustering the 59 kinase substrates
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phosphorylated on titanium (Supporting Information Table 6).
Phosphorylation of four peptides induce the activation of FAK
signalling. Moreover, MAPK (two peptides) and PI3K (three peptides)
signalling were activated also in cells in adhesion to titanium
(Supporting Information Figure 3c,d).
The activation of some signalling pathways on ECM and on
titanium revealed by PamChip array was validated by immunoblot
analysis, both in technical and biological replicates of cell lysates
(Figure 3a). Overall and in line with the PamChip analyses, ECM tend
to induce a higher kinase activity compared with titanium, as
signalling pathways such as FAK, ERK/MAPK, and PI3K/AKT path-
ways were more active in cells on ECM than on titanium, as shown in
Figure 3b–d by the quantification of the induced kinase relative to
the loading control in technical and biological replicates. This
highlights the importance of the peptide array as high‐throughput
screening technique to select candidate pathways.
Quantification of kinase substrate phosphorylation in the peptide
array (Supporting Information Figure 4a–c) followed the same trend
as the quantification of the putative kinases of each signalling
pathway by western blot (Figure 3b–d). The activation of signalling
F IGURE 2 Comparative kinomes of
MSCs on ECM and titanium. Heat map of
the 30 gene IDs of the parent proteins of
Markov‐positive phosphopeptides on ECM
and titanium (bottom) involved in 35
selected intracellular signalling pathways
(right) in IPA. Parent proteins of the
Markov‐positive peptides are indicated as
gene IDs (bottom). Green: activated in both
substrates; red: uniquely activated in ECM;
blue: uniquely activated on titanium; grey:
none. Colour scale bar represents log (p
value) of enrichment. Black arrows indicate
signalling pathways highlighted in the text.
ECM: extracellular matrix; IPA: Ingenuity®
pathway analysis; MSC: mesenchymal
stromal cell
F IGURE 3 Immunoblot analysis of
phosphoproteins confirmed the activation
of specific intracellular signalling pathways
revealed by PamChip. (a) Western blot
analysis of pFAK, pERK, and pAKT in
technical and biological replicates. β‐Actin
was used as loading control. (b–d)
Quantification of immunoblot band
intensities of the selected phosphorylated
kinases over β‐actin of technical and
biological replicates. Bars represent
average ± standard deviation.
ECM: extracellular matrix; Ti: titanium
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pathways revealed by IPA was the result of the phosphorylation of
multiple kinase substrates (Supporting Information Table 7). For
instance, the phosphorylation of eight peptides in PamChip revealed
the activation of PI3K/AKT signalling in cells on ECM (Figure 4;
Supporting Information Figure 4c), which was higher than on
titanium (four Markov‐positive peptides), confirming the higher
phosphorylation of pPKB on ECM compared with titanium
(Figure 3a,d).
3.3 | Functional consequences of reduced PI3K
activation
PamChip microarray analysis revealed that the PI3K/AKT signal-
ling pathway among others was activated in cells adhering to both
substrates (Figure 2), but with a higher activity on ECM than on
titanium (Figure 3a,d). The temporal kinetics of the peptides
clustered in PI3K/AKT signalling are displayed in Figure 4. PI3K
signalling has been shown to be important for several cellular
functions, including cell adhesion. We validated this by allowing
MSCs to adhere to ECM for 4 hr in the absence or presence of the
PI3K kinase inhibitors Wortmannin or LY290042. Figure 5a
shows that Wormannin significantly reduced cell attachment to
ECM in a dose‐dependent manner (p < 0.001 for 10 μM of
Wortmannin), by decreasing the number of cells in adhesion to
the ECM (Figure 5a, left) and increasing the number of floating
cells in culture medium (Figure 5a, right). Similarly, LY294002
increased the number of nonadherent cells (Figure 5b), albeit less
efficiently. This is most likely due to residual PI3K activity, as
shown in Figure 5c: Both Wortmannin and LY294002 selectively
inhibit PI3K signalling (as indicated by decreased phosphorylation
of its downstream target, PKB) at a concentration of 10 μM, but
Wortmannin showed a more prominent inhibitory effect. To
confirm that the increase in nonadherent cells in response to
PI3K inhibition was not due to induction of apoptosis by these
compounds, MSCs on ECM were treated for 4 hr with and without
PI3K inhibitors (Wortmannin 10 μM and LY294002 10 μM), and
cleaving of PARP and caspase 3 was measured by immunoblot
analysis as a hallmark of apoptosis. The presence of cleaved
caspase 3 was not detected in samples treated with and without
PI3K inhibitors, nor were cleaved PARP levels increased,
confirming that the PI3K inhibitors were not toxic (Figure 5d).
The phosphorylation of selected kinases such as PKB (as well as
ERK) was also confirmed to be reduced in cells cultured on titanium
compared to cultures on ECM, also when assessing nonadherent cells
(Supporting Information Figure 5a,b). Thus, we next investigated
adhesion of MSCs to titanium and showed that while the highest
concentration of PI3K inhibitors (10 μM) reduced adhesion, this
effect did not reach statistical significance, in accordance with the
F IGURE 4 Temporal phosphorylation kinetics of selected peptides involved in PI3K/AKT signalling pathways as annotated by IPA. Peptide
IDs and peptide sequences are displayed on Y axis; numbers indicate first and last amino acid of the complete human protein or the peptide
sequence based on Uniprot annotation. Phosphotyrosines are indicated in red. Peptides that were Markov‐positive uniquely for cell lysates on
ECM are indicated with *. Data represents average ± standard deviation of technical replicates. ECM: extracellular matrix; IPA: Ingenuity®
pathway analysis
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lesser PI3K activation in response to titanium engagement of MSCs
(Figure 5e). Overall, our data confirm the importance of PI3K
signalling in cell adhesion, and suggest that kinome activity
differences observed are reflected by functional consequences
in MSCs.
4 | DISCUSSION
In this study, we comprehensively described the kinome profiles of
human MSCs during adherence to a cell‐derived ECM and to
titanium, by successfully using PamChip array technology. MSCs on
the two substrates showed a substantial overlap of kinase signatures.
Cells on ECM typically activate kinase reactions that conform
classical kinetics, that is that maximum reaction speeds are seen
early in the experiment, and have higher level of active kinases.
Importantly, without a priori assumptions, we used the PamChip
kinase array to identify PI3K signalling and further functional
experiments showed its importance in MSC viability and adhesion.
This observation may guide rational design of novel scaffolds for
tissue engineering.
Cell‐surface interplay has been studied to develop biomaterials to
improve BTE (Gemini‐Piperni, Takamori, et al., 2014; Zambuzzi et al.,
2011). Upon cell adhesion to a surface, mechanical forces are converted
into biochemical signals by integrins, that induce the activation of FAK,
Src family kinases, and an intricate network of signalling pathways, such
as PI3K, MAPK ERK1/2, PKC, and Rho‐family GTPase, that eventually
modulate cell behaviour (Marie et al., 2014). Osteoblast adhesion is
controlled mainly by PKA, PKC, and RhoA proteins that promote cell
cycle arrest and mediate cytoskeletal rearrangements (Zambuzzi, Bruni‐
Cardoso, et al., 2009). In line with this, we showed that pathways such
as FAK, PAK, Paxillin, ILK, and Rho GTPase family signalling were
activated upon MSC adhesion to ECM and titanium. Moreover,
PamChip kinase array revealed the activation of ERK/MAPK signalling.
F IGURE 5 Functional effects of PI3K
signalling inhibition. (a) Number of cells in
adhesion to ECM (left) for 4 hr with
Wortmannin 0.1, 1, and 10 μM and number
of events floating in culture medium (right)
in same culture conditions. (b)
Quantification of MSCs in adhesion to
ECM with increasing concentrations of
LY294002 (left) and floating in culture
medium (right). (c) Immunoblot of pAKT
and pERK1/2 to confirm PI3K signalling
inhibition by Wortmannin 10 μM and
LY294002 10 μM in MSCs on ECM.
(d) Immunoblot validation of PARP,
caspase 3, and the relative cleaved forms in
extracts of MSCs on ECM without and with
PI3K inhibitors Wortmannin 10 μM and
LY294002 10 μM. (e) Number of cells
adherent to titanium (left) and
nonadherent (right) after 4 hr of culture
with Wortmannin 10 μM and LY294002
10 μM (left). Bars indicate
average ± standard deviation of multiple
independent experiments
(N = 3; **p < 0.01; ***p < 0.001; ‐no
inhibitors). ECM: extracellular matrix; LY:
LY294002; MSC: mesenchymal stromal
cell; WM: Wortmannin
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MAPKs are a central hub in controlling bone homoeostasis, as they are
activated by extracellular stimuli and ECM‐mediated integrin activation
via Src/FAK signalling network, but also promote osteoblast survival
and differentiation by controlling osteogenic transcription factors
(Greenblatt, Shim, & Glimcher, 2013; Marie et al., 2014). Cell adhesion
to an ECM has been studied through mass spectrometry showing the
high level of tyrosine phosphorylation in adhesion complexes, thus
revealing the importance of kinases in cell adhesion (Robertson et al.,
2015; Zaidel‐Bar & Geiger, 2010) The behaviour of calvarial osteoblasts
has been analyzed through PepChip kinase‐array screening technology.
Milani et al. (2010) studied calvarial osteoblasts in adhesion to
polystyrene and reported not only the induction of FAK, Src, PKA,
and PKC, but also kinases not directly related to cell adhesion such as
GSK3β and Rap1A. The activation of PKA, PKC, VEGF, and adducin‐1
(ADD1) was reported in calvarial osteoblast adhesion to hydroxyapatite
(Gemini‐Piperni, Milani, et al., 2014). Recently, Marumoto et al. (2017)
used the PepChip platform to study the interplay between ECM and
osteoblasts, showing that Hedgehog signalling regulates morphological
changes in calvarial osteoblasts during a 10‐day culture on Matrigel™,
confirming some of the findings by Chaves Neto et al. (2011) who
investigated the osteogenic differentiation on polystyrene. In our study,
PamChip kinase array was used to investigate how changes in the
kinomic signature regulate human MSC adhesion to diverse substrates,
such as an osteoblast‐derived ECM and titanium. PamChip contains a
lower number of kinase substrates than PepChip, but allows kinetic
measurements with strong reproducibility and giving quantification of
end‐point signals as well as temporal kinetics of the reaction (Baharani,
Trost, Kusalik, & Napper, 2017). Our PamChip results showed a big
overlap between the distributions of phosphorylation in cells on the two
surfaces, but also a delay in phosphorylation kinetics in cells cultured on
titanium compared with MSCs on ECM, highlighting the importance of
analyzing temporal kinetics.
PamChip is a cost‐effective high‐throughput array that can
simultaneously identify rapid changes in kinome profiles (Peppelenbosch,
2012). PamChip and other kinase‐array platforms drive hypothesis
formation, due to the variable number of putative upstream kinases that
could phosphorylate the peptides. They represent powerful tools to
select pathways that might be crucial in physiological functions, but the
kinase activation needs to be validated by immunoblot analysis
(Arsenault, Griebel, & Napper, 2011; Sikkema et al., 2009). We used
IPA for functional clustering of the peptides into signalling pathways, as
previously done (Kuijjer et al., 2014), and we confirmed it by fitting each
peptide in one specific signalling pathway. However, software to fit
phosphopeptides into cascade signalling networks needs to be imple-
mented with kinomic‐oriented tools.
In this study, PamChip revealed the activation of PI3K/AKT in
MSCs adhering to ECM and titanium, which corroborates with
previous findings on polystyrene and on hydroxyapatite (Gemini‐
Piperni et al., 2014; Milani et al., 2010). Conversely, PI3K/AKT
signalling was found to be downregulated during osteogenic
differentiation in standard culture conditions and on Matrigel
(Chaves Neto et al., 2011; Marumoto et al., 2017). The PI3K/AKT
signalling pathway regulates many cellular functions such as
proliferation, adhesion and migration, and its activation promotes
cell survival (Manning & Toker, 2017). In osteoblasts, PI3K was
shown to mediate BMP2 induction of osteogenic differentiation
(Baker, Sohn, & Tuan, 2015; Ghosh‐Choudhury et al., 2002;
McGonnellGrigoriadis, Lam, Price, & Sunters, 2012; Mukherjee &
Rotwein, 2009) and to interact with RUNX2 in controlling osteoblast
and chondrocyte differentiation and migration (Fujita et al., 2004),
though findings are still controversial as for the influence of PI3K
signalling in osteogenic differentiation (Kratchmarova, Blagoev,
Haack‐Sorensen, Kassem, & Mann, 2005; Viñals, López‐Rovira, Rosa,
& Ventura, 2002). PI3K signalling is involved in integrin‐mediated
signal transduction during cell adhesion (Chen, Appeddu, Isoda, &
Guan, 1996; King, Mattaliano, Chan, Tsichlis, & Brugge, 1997). In this
study, we showed that PI3K is involved in osteoblast adhesion to
ECM and titanium, in agreement to previous studies where PI3K‐
mediated AKT activity was shown to be reduced when PI3K
inhibitors were present in COS7 cells and MSCs in adhesion to
fibronectin (Chaudhary et al., 2000; Liu et al., 2010). When PI3K
inhibitors were used, the number of nonadherent cells increased,
with a stronger effect on ECM than titanium. This is probably due to
the fact that PI3K signalling was more active on ECM than on
titanium, as shown by the temporal kinetics of the PI3K kinase
substrates, thus making it easier to visualize the inhibitory effect and
highlighting the importance of performing kinetic analyses.
The mechanisms of cell adhesion to titanium has been
previously investigated by using FAK and Src phosphorylation as
biomarkers to monitor cell or biomaterials interplay, as FAK and
Src have been proven to be phosphorylated upon integrin
activation in cells when adhering to different substrates (Zambuzzi
et al., 2014, 2009; Zambuzzi, Milani, & Teti, 2010). Our study using
the PamChip kinase array showed FAK signalling activation upon
adhesion to titanium, confirming these previous findings. Further
studies are needed to investigate how the cell‐derived ECM as
coating for titanium scaffolds would influence the kinome profile
and osteoblast adhesion, to implement the use of ECM and
titanium in BTE applications.
In summary, with this study we used a multiplex peptide array
technology to assess global tyrosine kinase changes upon cell
adhesion, showing that osteoblasts adhering to ECM exhibited a
similar kinase signature compared with titanium, but with higher
levels of active kinases present in MSCs on ECM. We successfully
used PamChip kinase substrate platform to comprehensively study
rapid changes in the phosphoproteomes of MSCs, and to
investigate specific pathways, highlighting the importance of
PI3K signalling in osteoblast viability and adhesion. We thus
contributed to disentangle kinomic changes upon cell adhesion to
different substrates, to develop biomaterials to improve BTE
applications.
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